HEAL TECHNOLOGY
Live / Registered — Registered (as of 26 Nov 2024)
What this means for you
Registered since 26 Nov 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97871705
- Registration number
- 7575527
- Mark type
- Design + words
- Filed
- 04 Apr 2023
- Published for opposition
- 24 Sept 2024
- Registered
- 26 Nov 2024
- Attorney of record
- Kathryn A. Gromlovits
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of strokes and neurovascular disorders; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of neurological disorders, in particular neurological disorders affecting the central nervous system, the peripheral nervous system and the autonomic nervous system; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of brain injury, in particular stroke, brain trauma and global ischemia; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of neurodegenerative disorders; Pharmaceutical preparations and natural dietary supplements for treatment and alleviation of symptoms and causes of stroke and dementia in particular, Alzheimer's disease, Parkinson's disease, senile dementia and Huntington's disease; Pharmaceutical preparations and additives in the nature of dietary supplements for neuroprotection in particular for treatment and alleviation of symptoms of strokes; Medical instruments and apparatus, namely, delivery apparatus for fibrin sealant and fibrin scaffold; Bio-functional antithrombogenic and endothelialisation coatings, namely, drug delivery agents in the form of a coating for stents that facilitate the delivery of a wide range of pharmaceuticals for treatment of neurovascular diseases; Biological skin tissue intended for subsequent implantation; Tissues for surgical use being surgical implants comprised of living tissues; Pharmaceutical preparations in liquid form for the treatment of neurological and neurovascular disorders; pharmaceutical preparations, namely, liquid embolic agents
- Class 010 — Medical apparatus: Surgical and medical apparatus for use in treating stroke and blockage or inflammation of cerebral vessels; surgical devices and instruments; Medical stents in the nature of surgical implant made of synthetic materials for use in soft tissue repair or the reconstruction of soft tissue deficiencies; Grafts being surgical implants made of artificial materials; Flow diverters, namely, surgical implants comprised of artificial materials; Medical guidewires and medical filters being blood filters, for use in the fields of Radiology, Cardiology and Neurology for the treatment of strokes and neurovascular disorders; Surgical and medical instruments, namely, stent-retrievers and stents for blood and blood components for medical purposes for use in the radiology, cardiology and neurology sectors, in particular for treating strokes and neurovascular disorders; Medical recanalisation devices for use in treating blood clots; Medical embolisation devices for use in treating hemoptysis; Medical application systems for surgical and medical apparatus, devices and instruments, in particular catheters; Medical devices, namely, pulse generators used with a neurostimulation system for neurostimulation; Prosthetic tissues for vascular use; Medical electrodes for the simulation of nerve paths; Medical electrodes for the treatment of epilepsy and Alzheimer's disease
Owner
- Acandis GmbH, Pforzheim, DE
- Acandis GmbH, Pforzheim, DE
- Acandis GmbH, Pforzheim, DE
Prosecution history
- 26 Nov 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Nov 2024 — REGISTERED-PRINCIPAL REGISTER
- 24 Sept 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Sept 2024 — PUBLISHED FOR OPPOSITION
- 04 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Aug 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Aug 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Aug 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Aug 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Jul 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Jul 2024 — NON-FINAL ACTION E-MAILED
- 30 Jul 2024 — NON-FINAL ACTION WRITTEN
- 27 Jun 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jun 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED